December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Immunogen Inc (NQ: IMGN )

7.210 USD UNCHANGED
Streaming Delayed Price Updated: 7:19 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Immunogen Inc

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SLN VVOS UTHR
From Benzinga
82 Biggest Movers From Yesterday
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares surged 60.4% to close at $24.60 on Monday. Nantkwest Inc ... 
Tags CCM NK Trading Ideas
From Benzinga
Stocks That Hit 52-Week Highs On Friday
Friday's session saw 466 companies set new 52-week highs. Key Facts: Tesla (NASDAQ: TSLA) was the company with ... 
Tags RFL FTCH CLNE
From Benzinga
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FHTX BEAM STOK
From Benzinga
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the ... 
Tags Benzinga IGMS MRK
From Benzinga
Interesting IMGN Put And Call Options For July 2021
Investors in ImmunoGen, Inc. (IMGN) saw new options become available this week, for the July 2021 expiration.. 
Tags Stocks
From Market News Video
Recap: Immunogen Q3 Earnings
Shares of Immunogen (NASDAQ:IMGN) rose 3.3% in pre-market trading after the company reported Q3 results. Quarterly ... 
Tags Earnings News IMGN
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags EPZM AVIR IBB
From Benzinga
Earnings Scheduled For November 6, 2020
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly earnings at ... 
Tags Benzinga Markets PAR
From Benzinga
Earnings Outlook for Immunogen
On Friday, November 06, Immunogen (NASDAQ:IMGN) will release its latest earnings report. Benzinga's outlook for Immunogen is ... 
Tags Earnings Market News IMGN
From Benzinga
Why that hot stock in your portfolio might be no better than a lottery ticket
More gambling goes on in the stock market than in all the world’s casinos combined. 
Tags AGEN BCRX ASTC
From MarketWatch
Week In Review: Fosun's Gland Pharma Approved For $814 Million IPO In India
India's Gland Pharma, a majority-owned subsidiary of Shanghai Fosun Pharma, was approved for an $814 million IPO on India's Sebi exchange (see story). The Hyderabad-based drug company makes generic... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Week in Review: Fosun's Gland Pharma Approved for $814 Million IPO in India
Deals and Financings   India 's Gland Pharma, a Shanghai Fosun subsidiary, was approved to conduct an $814 million IPO in India to support its injected drug portfolio; Huadong Medicine in-licensed... 
From ChinaBio® Today
Week in Review: Fosun's Gland Pharma Approved for $814 Million IPO in India
Deals and Financings   India 's Gland Pharma, a Shanghai Fosun subsidiary that specializes in generic injected drugs, was approved to conduct an $814 million IPO in India ; Huadong Medicine in-licensed... 
From ChinaBio® Today
Tuesday's ETF Movers: TAN, XBI
In trading on Tuesday, the Invesco Solar ETF is outperforming other ETFs, up about 4.2% on the day. Components of that ETF showing particular strength include shares of Daqo New Energy, up about 11.8%... 
Tags ETFs
From ETF Channel
Huadong Med Acquires ADC for Ovarian Cancer in $305 Million Agreement
Huadong Medicine in-licensed greater China rights to an antibody-drug conjugate developed by ImmunoGen in a $305 million agreement. IMGN853 (mirvetuximab soravtansine) is in a US Phase III trial for... 
From ChinaBio® Today
Are These The Best Penny Stocks To Buy Now Or Should You Wait?
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Add Up The Pieces: LABU Could Be Worth $93
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
10 Biggest Price Target Changes For Tuesday
JP Morgan boosted Advance Auto Parts, Inc. (NYSE: AAP) price target from $183 to $190. Advance Auto Parts shares rose 0.1% to ... 
Tags Penny Stocks AAP Pre/Market Outlook
From Benzinga
62 Biggest Movers From Yesterday
Gainers Westwater Resources, Inc. (NASDAQ: WWR) shares surged 87.3% to close at $8.28 on Monday after surging 49% on Friday. The ... 
Tags HGEN AMC Top Gainers
From Benzinga
50 Stocks Moving In Monday's Mid-Day Session
Gainers MyoKardia, Inc. (NASDAQ: MYOK) shares climbed 58.2% to $220.80 after Bristol-Myers Squibb announced a multi-billion ... 
Tags HGEN AMC XPEV
From Benzinga
Looking Into Immunogen's Return On Capital Employed
During Q2, Immunogen (NASDAQ: IMGN) brought in sales totaling $15.03 million. However, earnings decreased 22.88%, resulting in a loss of ... 
Tags News Earnings IMGN
From Benzinga
What Are The Best Penny Stocks To Buy Now? 5 Moving Premarket
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
12 Healthcare Stocks Moving In Monday's Pre-Market Session
Gainers MyoKardia (NASDAQ:MYOK) stock rose 58.13% to $220.76 during Monday's pre-market session. The company's market cap ... 
Tags SINT NMTR Healthcare Stocks Pre/Market Movers
From Benzinga
Benzinga's Top Upgrades, Downgrades For October 2, 2020
Upgrades According to Evercore ISI Group, the prior rating for Splunk Inc (NASDAQ: SPLK) was changed from In-Line to Outperform. ... 
Tags Upgrades Initiations Benzinga
From Benzinga
The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference
Biotech stocks continued to remain under pressure in the week ended Sept. 11, swayed by the volatility that was evident in the broader ... 
Tags AGEN Health Care Autolus Therapeutics
From Benzinga
We Did The Math PBE Can Go To $74
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Immunogen Inc (IMGN) Q2 2020 Earnings Call Transcript
IMGN earnings call for the period ending June 30, 2020. 
Tags IMGN Market News
From Motley Fool
The Daily Biotech Pulse: Sanofi-GSK Land $2.1M Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 30) Achieve Life Sciences Inc (NASDAQ: ACHV) Annexon ... 
Tags Market News XBI EDSA
From Benzinga
Immunogen: Q2 Earnings Insights
Shares of Immunogen (NASDAQ:IMGN) moved higher by 3.0% in pre-market trading after the company reported Q2 results. Quarterly ... 
Tags Earnings Market News News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.